ask="20.80"
ask_size="400"
average_daily_volume="165865"
bid="17.65"
bid_size="2100"
book_value="7.04"
change="-0.25"
change_from_200_day_moving_average="3.76"
change_from_50_day_moving_average="-0.43"
change_from_52_week_high="-3.55"
change_From_52_week_low="8.40"
change_in_percent="-1.19%"
close="20.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.17"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="18634000"
high="21.25"
high_52_weeks="24.30"
last_trade_date="2/10/2017"
last_trade_price="20.75"
last_trade_size="2663"
last_trade_time="4:00pm"
low="20.55"
low_52_weeks="12.35"
market_capitalization="591.69M"
moving_average_200_day="16.99"
moving_average_50_day="21.18"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="36.60"
open="21.00"
pe_ratio="N/A"
peg_ratio="-0.57"
percent_change_from_200_day_moving_average="+22.10%"
percent_change_from_50_day_moving_average="-2.04%"
percent_change_from_52_week_high="-14.61%"
percent_change_from_52_week_low="+68.02%"
previous_close="21.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.98"
price_per_sales="1996.05"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="22.14"
stock_exchange="NGM"
symbol="RVNC"
volume="154741"
weeks_range_52="12.35 - 24.30"
